Avricore Health is a health care and pharmaceutical startup based in Canada, established in 1996. The company is dedicated to becoming a health innovator and applying technologies at the forefront of science to core health issues at the community pharmacy level. Their slogan "Committed to becoming a health innovator and applying technologies at the forefront of science" reflects their commitment to leveraging innovative technologies for enhancing health.
Their vision is to empower consumers, patients, and pharmacists with innovative 21st-century products, services, and information to monitor and optimize health. Recently, the company secured a $1.54M Post-IPO Equity investment on 04 February 2021. This investment is indicative of the confidence that investors have in the potential of Avricore Health and its capabilities to drive innovation and impact in the health industry. As a venture capital firm, it is crucial to monitor startups like Avricore Health that are focusing on disruptive health technologies and services, as they have the potential to make a substantial impact on the industry. With the recent investment, it is evident that Avricore Health is gaining momentum and is poised for further growth and development in the coming years.Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Post-IPO Equity | $1.54M | - | 04 Feb 2021 |
No recent news or press coverage available for Avricore .